FDA Crackdown Reignites Controversy Over Ethics Of '3-Parent Embryo'

The FDA said the procedure that led to the first "three-parent embryo," violates the regulator's restrictions on genetic engineering. The clampdown could have widespread implications for other advancements in the controversial field of human genetic modification.
Subscribe to The Morning Email.
Wake up to the day's most important news.
CONVERSATIONS